MedTrace Logo

Kinesia 360 Parkinson's Monitoring Study

NCT02657655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-02-19

No results posted yet for this study

Summary

Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.

Conditions

Interventions

DEVICE

Kinesia 360

Kinesia 360 includes a mobile app and wireless motion sensors worn on the patient's wrist and ankle to quantify tremor, dyskinesias, and mobility throughout the day as he or she goes about normal activities. The app includes electronic diaries enable patients to rate their symptoms and log when medications are taken. Data is transferred to a cloud server where motor symptom reports are generated for clinician review.

Sponsors & Collaborators

  • University of South Carolina School of Medicine, Greenville

    collaborator UNKNOWN

  • University of Rochester

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • Prisma Health-Upstate

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • The Cleveland Clinic

    collaborator OTHER

  • Great Lakes NeuroTechnologies Inc.

    lead INDUSTRY

Principal Investigators

  • Dustin Heldman, PhD · Great Lakes NeuroTechnologies Inc.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657655 on ClinicalTrials.gov